News

Statera Biopharma a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today that the Company intends to…
Read More...

Inmagene Biopharmaceuticals announces that the U.S. Food and Drug Administration (FDA) cleared its investigational new drug (IND) application for the drug candidate IMG-004, a…
Read More...

Editas Medicine, Inc. a leading genome editing company, announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation to EDIT-301, an investigational, gene…
Read More...

The U.S. Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) injection, Eli Lilly and Company's (NYSE: LLY) new once-weekly GIP (glucose-dependent insulinotropic…
Read More...

Neurocrine Biosciences, Inc. announced that it has received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for valbenazine as a treatment for Huntington…
Read More...

Stealth BioTherapeutics Corp, a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial…
Read More...

Mindset Pharma Inc. a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric…
Read More...

Nuvig Therapeutics, Inc., announced the launch of the company to develop novel therapeutics that induce mechanisms of immune homeostasis and treat autoimmune diseases without…
Read More...

Artax Biopharma, Inc., a clinical stage biotechnology company focused on transforming the treatment of T Cell-mediated pathologies, announces the close of a $26 million financing round…
Read More...

Eli Lilly and Company and Incyte announced the U.S. Food and Drug Administration (FDA) has approved OLUMIANT (baricitinib) for the treatment of COVID-19 in hospitalized adults requiring…
Read More...

Neuvivo, a biopharmaceutical company dedicated to delivering an effective, safe ALS treatment to patients, announced that it has initiated cGMP manufacturing of NP001 for the treatment…
Read More...

Sound Pharmaceuticals, Inc. (SPI) is pleased to announce that is has received a $1.1M supplement to its $3.1M National Center for Advancing Translational Sciences (NCATS) Award,…
Read More...

Eiger Biopharmaceuticals Inc. and AnGes Inc. announced that the companies entered into an agreement for the regulatory approval, marketing, and distribution of Zokinvy (lonafarnib) for…
Read More...

MOMA Therapeutics, a biopharmaceutical company discovering the next generation of precision medicines by targeting molecular machines that underlie human disease, announced the…
Read More...

Thermo Fisher Scientific today launched a new collection of qPCR biopharma offerings to help accelerate drug development to meet a growing demand for novel biologics. The QualTrak…
Read More...

Pfizer Inc. and Biohaven Pharmaceutical Holding Company Ltd. announced that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven, the maker of…
Read More...

Hitachi High-Tech Corporation has entered into a strategic partnership (the Partnership) with Invivoscribe, Inc. ("Invivoscribe"), a global provider of blood cancer testing kits and…
Read More...

Twist Bioscience Corporation a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced it has entered into a…
Read More...

GNS Healthcare, the leader in the use of "Virtual Patients", Causal AI and simulation technology for biopharmaceutical companies, announced a collaboration with Arvinas, Inc. a…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the termination of its collaboration and license agreements with Bavarian Nordic that leverage Bavarian…
Read More...